This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2016 Jul 21;375(3):275-8.

doi: 10.1056/NEJMe1606015.

A Challenge in Vaccine Development--Neisseria meningitidis Serogroup B

Affiliations

PMID: 27468064
DOI: 10.1056/NEJMe1606015

Editorial

A Challenge in Vaccine Development--Neisseria meningitidis Serogroup B

Jerome H Kim. N Engl J Med. 2016.

. 2016 Jul 21;375(3):275-8.

doi: 10.1056/NEJMe1606015.

Author

Affiliation

¹ From the International Vaccine Institute, Seoul, South Korea.

PMID: 27468064
DOI: 10.1056/NEJMe1606015

No abstract available

PubMed Disclaimer

Comment on

Immunogenicity of a Meningococcal B Vaccine during a University Outbreak.
Basta NE, Mahmoud AA, Wolfson J, Ploss A, Heller BL, Hanna S, Johnsen P, Izzo R, Grenfell BT, Findlow J, Bai X, Borrow R. Basta NE, et al. N Engl J Med. 2016 Jul 21;375(3):220-8. doi: 10.1056/NEJMoa1514866. N Engl J Med. 2016. PMID: 27468058 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations